Full-Time

Staff Accountant

Posted on 3/27/2026

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$73k - $100k/yr

Peabody, MA, USA

In Person

Category
Accounting (2)
,
Required Skills
Oracle
Excel/Numbers/Sheets
Requirements
  • BS in Accounting
  • 7+ years of experience with heavy emphasis on full-cycle
  • Accounts Payable and month-end close responsibilities
  • Experience with Oracle or other large ERP system, including General Ledger, Fixed Assets, Accounts Receivable/Accounts Payable
  • Advanced proficiency in Microsoft Excel and Microsoft Suite and/or Google Suite
  • Strong analytical skills, critical thinking mindset, ability to troubleshoot
  • Proficient with spreadsheets (VLOOKUPs, Pivot tables)
  • Strong understanding of system design principles, scalability, and security best practices
Responsibilities
  • Oversee the full-cycle Accounts Payable process, from coding and data entry to matching purchase orders and obtaining approvals
  • Manage vendor inquiries, reconcile monthly statements, and maintain clean aging reports
  • Prepare and execute weekly check runs, Automated Clearing House payments, and wire transfers
  • Maintain W-9 records and assist in the year-end 1099 filing process
  • Preparation of monthly journal entries, balance sheet reconciliations, accruals, reserves, intercompany transactions and eliminations, upload of foreign subsidiary ledgers to Oracle
  • Review of departmental spend against budget; investigate variances to budget
  • Key contributor on cross-functional project teams to achieve desired results
  • Documentation of key controls and processes
  • Special projects and analysis, as needed
  • Prepare documentation and schedules for external audits
Desired Qualifications
  • Demonstrated understanding of US Generally Accepted Accounting Principles
  • Ability to grasp and make “big picture” decisions, while maintaining strong attention to detail
  • Strong analytical and problem-solving skills
  • Ability to work effectively within a small, cohesive finance team
  • Ability to interact with external auditors and resolve issues quickly under supervision of the Corporate Controller
  • Strong verbal and written communication skills
  • Excellent organizational and problem-solving skills
  • Proactive and supportive of change
  • Experience with QuickBooks (for sister company)
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Cell signaling market grows to $7.11 billion by 2030 at 7.3% CAGR.
  • Bio-Techne adds Simple Western validation to CST antibodies in 2023.
  • CST invests $17.5M in Manchester property in July 2022 for expansion.

What critics are saying

  • Leveragen nanobodies displace CST monoclonal antibodies in 12-24 months.
  • Lunaphore scales single B cell screening, eroding CST revenue in 12-18 months.
  • Visiopharm dependency fails if Indica Labs captures market in 18-36 months.

What makes Cell Signaling Technology unique

  • CST launches SignalStar Multiplex IHC for 8-plex amplification in two days.
  • CST partners with Visiopharm to integrate SignalStar with Phenoplex software.
  • CST expands chimeric monoclonal antibodies to mouse, horse, and feline species.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cell Signaling Technology who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Company News

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.

AZoNetwork
Sep 14th, 2023
Flexible Spatial Biology Solution for Up to 8-Plex Amplification in Two Days: CST Launches SignalStar™ Multiplex IHC

Cell Signaling Technology (CST) , a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.

INACTIVE